western union transfer fee FORNER-CORDERO I. 1, NAVARRO-MONSOLIU R. 1, MUÑOZ-LANGA J. 2
1 Lymphedema Unit, Rehabilitation Department, Hospital Universitario La Fe, Valencia, Spain
2 Clinical Oncology Unit, Hospital Universitario Dr. Peset, Valencia, Spain
Corresponding author: Isabel Forner-Cordero, MD
Andres Mancebo 3 6, 12
46023 – Valencia (Spain)
Phone: 34-649 17 98 52
E-mail: iforner@saludalia.com
ABSTRACT
Purpose: To assess the efficacy and tolerability of the combination
of Lymphomyosot with compression hosiery in the maintenance
treatment of breast cancer-related lymphedema.
Methods: Female patients diagnosed with breast cancer, who had
undergone unilateral breast surgery and exhibited stage II-IV arm
lymphedema secondary to treatment received oral Lymphomyosot
and were monitored over a period of 6 months. Primary outcome
measure was the percentage reduction in lymphedema volume.
Results: Thirty-six patients, with a mean age of 60 years and a
long (4 years) disease duration were included. The reduction of
lymphedema volume was 29.5% (95% CI, 15.0 to 43.9) at month
1, 31.5% (95% CI, 13.2 to 49.9) at month 3, and 41.2% (95% CI,
17.6 to 64.9) at month 6. Lymphomyosot was well-tolerated.
Conclusions: Lymphomyosot combined with compression hosiery
might be an efficacious and well-tolerated therapeutic alternative
for the maintenance treatment of patients with breast cancerrelated
lymphedema.
KEY WORDS: Breast cancer, lymphedema, compression hosiery,
compression therapy, Lymphomyosot
